About 600 reports

  • 9.2 INNOVATIVE EARLY-STAGE APPROACHES
  • SETTING WILL LARGELY REMAIN UNADDRESSED

(Accessed: ## August 2019).

  • Targeted Therapy
  • United States
  • Forecast
  • AstraZeneca PLC
  • Roche Group
  • OVERVIEW OF THE DEVELOPMENT PIPELINE IN PCA

So you' ve got this one plus one equals two.

  • Targeted Therapy
  • East Asia
  • United States
  • Forecast
  • Pfizer Inc.
  • F) Cutaneous lupus erythematosus
  • A) Systemic sclerosis

FDA Allows Pediatric Enrollment in Phase ##/ ## Trial of FCX-## Gene Therapy for RDEB.

  • Targeted Therapy
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.
  • Biologics Market Segmentation

Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.

  • Targeted Therapy
  • United States
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F) Pipeline by molecule type and stage of development
  • Overall

RNAi gene therapy and antisense gene therapy make up the least, with one (##%) molecule each, while stem cell therapy and antisense oligonucleotide each represent two (##%) molecules.

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • gives the failure rate by molecule type at each phase. At Phase I, cell and gene therapies
  • C) Attrition rate by molecular target

There were no completed clinical trials with cell and gene therapies in Phase II.

  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • OVERVIEW OF THE DEVELOPMENT PIPELINE IN DLBCL

The ranking system ranges from one (##) to five (##), with ## being the least favorable score and ## being the most favorable.

  • Cancer
  • Lymphoma
  • Targeted Therapy
  • United States
  • Forecast
  • Source: GBI Research, Proprietary Marketed Product Database Abbreviations: CTA: clinical trial authorization; IND: investigational new drug; mAb: monoclonal Antibody

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Targeted Therapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.
  • Global Biologics Market, Historic and Forecast Growth Rates, Split By Segment, 2013 - 2021
  • Biologics Market Segmentation

ADVANCES IN BIO GENERICS AND GENE THERAPY ARE DRIVING THE THERAPEUTIC PROTEINS MARKET.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Market segmentation Based on its product, the global Biologics Market is segmented into interleukins, monoclonal antibody, vaccines, gene therapy, growth factors, and others.

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • United States
  • PHASE II
  • PHASE I

PLOS ONE; ##(##): E##.

  • Targeted Therapy
  • United States
  • Allergan plc
  • Novartis AG
  • Ophthotech Corporation
  • Breast Cancer Therapeutics Market, Global, Clinical Trial Failure Rates by Molecule
  • Syntheticpeptide

Cellular immunotherapies and gene therapies had the least participants, at ##.

  • Cancer
  • Targeted Therapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • Global Biologics Market, Historic and Forecast Growth Rates, Split By Segment, 2013 - 2021
  • Biologics Market Segmentation

ADVANCES IN BIO GENERICS AND GENE THERAPY ARE DRIVING THE THERAPEUTIC PROTEINS MARKET.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.

PLoS ONE; ##(##): ##-## BMS (2015). ##K Annual report.

  • Chemotherapy
  • Targeted Therapy
  • Therapy
  • Market Size
  • Merck & Co., Inc.

" I think there is potential for siponimod if it gets the SPMS label based on one trial.

  • Targeted Therapy
  • United States
  • Forecast
  • Novartis AG
  • TG Therapeutics, Inc.
  • Regenerative Medicines
  • 3.2.3 Global Biologics Market by Product-Category

Morgan Table ##: Chemical Drugs vs.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Patients in the ERASURE study were randomized ##:##:## to receive subcutaneous Cosentyx ##mg, ##mg, or placebo, whereas the FIXTURE trial had an additional comparative arm of etanercept ##mg dosed twice weekly (##:##:##:##).

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY PIPELINE

The remaining ##% contains a range of less-common molecule types, including cell therapies, gene therapies, synthetic peptides and biologics.

  • Targeted Therapy
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Targeted Therapy
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • Immune Design
  • HS-10296

PLoS One; ##(##): e## Lee P, et al. (2012).

  • Targeted Therapy
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novartis AG
  • Roche Group

HEALTH AND SAFETY EXECUTIVE; ##(##): ##-##.

  • Targeted Therapy
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • Breast Cancer Therapeutics Market, Global, Clinical Trial Failure Rates by Molecular
  • 5.1.2 FAILURE RATE BY PHASE AND MOLECULE TYPE

Second and third quartile values could not be obtained for cell and gene therapies as there was only one recorded trial.

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Genentech, Inc.
  • Novartis AG
  • NS5B polymerase

Hepatology, Medicine and Policy; ##(##): ## Forns X, et al. (2017).

  • Targeted Therapy
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group

Rucaparib is a top-of-the-line pharmaceutical preparation for the repair polymerase of DNA polymerase-## (PARP-##) poly-ADP.

  • Targeted Therapy
  • World
  • AbbVie Inc.
  • AstraZeneca PLC
  • Clovis Oncology, Inc.
  • Cancer Supportive Care Market, Global, Pipeline for Cancer Supportive Care
  • Cancer Supportive Care Market, Global, Overall Pharmaceutical Industry Pipeline by

Arthritis Research Therapy; ##(##): ##-## Bridges D, et al. (2001).

  • Targeted Therapy
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Insys Therapeutics, Inc.
  • 7.2 Co-development Deals

It is not limited to small molecules and contains a wide range of other molecule types such as mAbs, proteins, gene therapies, vaccines and cell therapies.

  • Targeted Therapy
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Chengdu Research Center of Anti-tumor Gene Therapy has been approved to establish in the company.

  • Targeted Therapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd

Arthritis Care and Research; ##(##): ##-## SingHealth (2014).

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.
  • B) Pipeline by molecule type
  • C) Pipeline by molecule type and stage of development

In comparison to small molecules, the sum of deal values for gene therapies was minute.

  • Targeted Therapy
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.

The company' s drug platforms include biologics, small molecules, millamolecules, antibody-drug conjugates, gene therapy, RNA oligonucleotides and drug delivery technology.

  • Targeted Therapy
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology
  • Bristol-Myers Squibb Company